For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250217:nRSQ3269Xa&default-theme=true
RNS Number : 3269X Alkemy Capital Investments PLC 17 February 2025
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR
FORM ANY PART OF AN OFFER TO SELL OR ISSUE, OR A SOLICITATION OF AN OFFER TO
BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES IN THE UNITED STATES,
AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN
WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON TO WHOM IT
IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NO PUBLIC OFFERING OF THE
FUNDRAISE SHARES IS BEING MADE IN ANY SUCH JURISDICTION. ANY FAILURE TO COMPLY
WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF
SUCH JURISDICTIONS.
THIS ANNOUNCEMENT IS NOT FOR PUBLIC RELEASE, PUBLICATION OR DISTRIBUTION, IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,
AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN
WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE
MARKET ABUSE REGULATION NO. 596/2014 ("MAR") AS IN FORCE IN THE UNITED KINGDOM
PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
17 February 2025
Alkemy Capital Investments Plc
Placing to raise £1.035 million
Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) is pleased to announce
that it has raised £1.035 million in an oversubscribed placing of 828,000 new
ordinary shares at a placing price of £1.25 per share ("Placing Shares").
This includes a subscription of £150,000 from director Paul Atherley,
£75,000 from director Sam Quinn, £50,000 from director Vikki Jeckell and
£10,000 from director Helen Pein. Quark Financial was the Financial Advisor
to the transaction.
The net proceeds will be used to further the development of TVL's lithium
hydroxide processing faclility in Teesside and for general working capital
purposes.
Following the placing, the directors will have the following beneficial
shareholdings in the Company:
Number of new Shares subscribed Resulting number of Shares % of enlarged capital
Paul Atherley 120,000 3,520,559 36.13%
Sam Quinn 60,000* 506,428 5.20%
Vikki Jeckell 40,000 40,000 0.41%
Helen Pein 8,000 40,142 0.41%
(*)Includes a subscription of £50,000 via Lionshead Consulting Limited and
£25,000 via Silvertree Partners, in which Mr Quinn has an interest.
Subscribers in the placing will be entitled to one warrant for every two
shares subscribed at an exercise price of £2 per share for two years from the
date of issuance. If at any time during the two year period the Company's
shares price exceeds £4 for a ten day period an accelerator provision will
apply and the Company may elect to enforce the exercise of the warrants.
In addition Alkemy has issued 100,000 new ordinary shares in relation to fees
payable to an adviser ("Fee Shares").
The placing and issue of the Placing Shares and Fee Shares are conditional
upon and an application will be made for 928,000 ordinary shares to be
admitted to the official list (Standard Segment) of the FCA and to trading on
the Main Market of the London Stock Exchange ("Admission") and Admission is
expected to occur at 8.00 a.m. on 24 February 2025.
In accordance with the FCA's Disclosure Guidance and Transparency Rules, the
Company confirms that following Admission, the Company's enlarged issued
ordinary share capital will comprise 9,742,851 ordinary shares each with a
right to vote and with no shares held in treasury. Therefore, following
Admission, the above figure may be used by shareholders in the Company as the
denominator for the calculations to determine if they are required to notify
their interest in, or a change to their interest in the Company, under the
FCA's Disclosure Guidance and Transparency Rules.
In addition, the Company has issued 65,000 warrants exerciseable at £0.88 per
share, 50,000 warrants exerciseable at £1.25 per share and 120,000 warrants
exerciseable at £1.75 per share.
Further information
For further information, please visit the Company's website:
www.alkemycapital.co.uk (http://www.alkemycapital.co.uk) or
www.teesvalleylithium.co.uk (http://www.teesvalleylithium.co.uk)
-Ends-
Alkemy Capital Investments Plc Tel: 0207 317 0636
info@alkemycapital.co.uk (mailto:info@alkemycapital.co.uk)
Zeus Tel: 0203 829 5000
Forward Looking Statements
This news release contains forward‐looking information. The statements are
based on reasonable assumptions and expectations of management and Alkemy
provides no assurance that actual events will meet management's expectations.
In certain cases, forward‐looking information may be identified by such
terms as "anticipates", "believes", "could", "estimates", "expects", "may",
"shall", "will", or "would". Although Alkemy believes the expectations
expressed in such forward‐looking statements are based on reasonable
assumptions, such statements are not guarantees of future performance and
actual results or developments may differ materially from those projected. In
addition, factors that could cause actual events to differ materially from the
forward-looking information stated herein include changes in market
conditions, changes in metal prices, general economic and political
conditions, environmental risks, and community and non-governmental actions.
Such factors will also affect whether Alkemy will ultimately receive the
benefits anticipated pursuant to relevant agreements. This list is not
exhaustive of the factors that may affect any of the forward‐looking
statements. These and other factors should be considered carefully and readers
should not place undue reliance on forward-looking information.
The Notification of Dealing Form provided in accordance with the requirements
of the Market Abuse Regulation in relation to the transaction listed above is
set out below.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Paul Atherley
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.25 120,000
d) Aggregated information
- Aggregated volume 120,000
- Price £1.25
e) Date of the transaction 24/02/2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Sam Quinn
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.25 60,000
d) Aggregated information
- Aggregated volume 60,000
- Price £1.25
e) Date of the transaction 24/02/2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Vikki Jeckell
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.25 40,000
d) Aggregated information
- Aggregated volume 40,000
- Price £1.25
e) Date of the transaction 24/02/2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Helen Pein
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.25 8,000
d) Aggregated information
- Aggregated volume 8,000
- Price £1.25
e) Date of the transaction 24/02/2025
f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEUNURRVWUUAUR